Cargando…
An unexpected strategy to alleviate hypoxia limitation of photodynamic therapy by biotinylation of photosensitizers
The most common working mechanism of photodynamic therapy is based on high-toxicity singlet oxygen, which is called Type II photodynamic therapy. But it is highly dependent on oxygen consumption. Recently, Type I photodynamic therapy has been found to have better hypoxia tolerance to ease this restr...
Autores principales: | An, Jing, Tang, Shanliang, Hong, Gaobo, Chen, Wenlong, Chen, Miaomiao, Song, Jitao, Li, Zhiliang, Peng, Xiaojun, Song, Fengling, Zheng, Wen-Heng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9038921/ https://www.ncbi.nlm.nih.gov/pubmed/35469028 http://dx.doi.org/10.1038/s41467-022-29862-9 |
Ejemplares similares
-
Hypoxia-activated NIR photosensitizer anchoring in the mitochondria for photodynamic therapy
por: Xu, Feng, et al.
Publicado: (2019) -
Synchronous delivery of oxygen and photosensitizer for alleviation of hypoxia tumor microenvironment and dramatically enhanced photodynamic therapy
por: Guo, Xiaomeng, et al.
Publicado: (2018) -
Perfluorocarbon Nanoemulsions with Fluorous Chlorin-Type Photosensitizers for Antitumor Photodynamic Therapy in Hypoxia
por: Nguyen, Minh Tuan, et al.
Publicado: (2023) -
Chemiluminescence in Combination with Organic Photosensitizers: Beyond the Light Penetration Depth Limit of Photodynamic Therapy
por: Gao, Jie, et al.
Publicado: (2022) -
Anti-Hypoxia Nanoplatforms for Enhanced Photosensitizer Uptake and Photodynamic Therapy Effects in Cancer Cells
por: Nkune, Nkune Williams, et al.
Publicado: (2023)